Cancer - Side effect drugs Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cancer - Side effect drugs

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John McCarthy who started this subject	5/18/2002 1:28:57 PM
From: John McCarthy	of 57

[2001]-[BNP7787]-[Baxter Oncology] ASTA Medica Onkologie and BioNumerik Pharmaceuticals agree upon strategic alliance Frankfurt/Main - the ASTA Medica closed a strategic alliance with the American Pharmaunternehmen BioNumerik Pharmaceuticals, Inc. with its division Onkologie for the development and marketing of the medicine BNP7787 developed by BioNumerik. The agreement covers all states except the United States, Canada and Japan. BNP7787 is a new Chemoprotektivum for the prevention of frequently occurring and serious side effects, e.g. with the Taxanbehandlung and platinum therapy against different cancer illnesses. translate.google.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next